-
Salesforce picks board member Robin Washington to be its next finance and operating leader
06 Feb 2025 03:02 GMT
…
Salesforce on Wednesday said former Gilead Sciences finance chief Robin Washington will … came in to the stock.
Shares of Salesforce slipped almost 2% …
-
Salesforce Appoints Robin Washington as President, COO, and CFO
05 Feb 2025 22:31 GMT
… previous roles, including CFO at Gilead Sciences and Hyperion, as well as … to a focus on profitability.
Shares of Salesforce dipped nearly 2% …
-
Dr Reddy’s shares plummet 4.4% in the wake of logging modest Q3 growth
24 Jan 2025 06:09 GMT
The shares of Dr Reddy’s Laboratories … a voluntary licensing agreement with Gilead Sciences to manufacture an HIV treatment … by splitting existing ₹5 shares into five ₹1 shares.
Comments
SHARE
Copy …
-
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
29 Dec 2024 15:02 GMT
… The last time I covered Gilead Sciences (NASDAQ:GILD) for Seeking Alpha … beneficial long position in the shares of GILD either through stock …
-
Gene Therapy Market Set for Explosive Growth, Projected to Reach USD 46.5 billion by 2030 at a CAGR of 22.8%
05 Feb 2025 06:25 GMT
… lucrative opportunities in the industry.
𝐓𝐨𝐩 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:
• Gilead Sciences
• Orchard Therapeutics.
• Bristol-Myers Squibb … and what are the market shares of each region in the …
-
Gilead Sciences invests $20.1 million in Assembly Biosciences
24 Dec 2024 04:20 GMT
… , by purchasing 940,499 shares of common stock. According … now holds 2,209,471 shares in Assembly Biosciences. This … strides in its collaboration with Gilead Sciences. The companies have amended … Biosciences, acquiring 940,499 shares of common stock.
In …
-
Validating Chromatographic Methods: Challenges, Tools, and Optimization
05 Feb 2025 01:34 GMT
… Director of Laboratory Informatics at Gilead Sciences. In this episode, Katy discusses … ’s method validation processes and shares how Empower’s Method Validation …
BIOGRAPHY
Associate Director, Laboratory Informatics, Gilead Sciences.
BIOGRAPHY
-
Gilead Sciences acquires $1.83 million in Xilio Therapeutics stock
19 Dec 2024 22:02 GMT
In a recent transaction, Gilead Sciences, Inc. (NASDAQ:GILD) expanded … a significant number of shares. The biopharmaceutical giant acquired … approximately 1,759,978 shares of Xilio's … Xilio's outstanding shares.
Following these transactions, Gilead …
-
Gilead Sciences Announces Third Quarter 2024 Financial Results
06 Nov 2024 21:07 GMT
… the accompanying tables.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical … , including the following: GILEAD®, GILEAD SCIENCES®, KITETM, AMBISOME®, ATRIPLA®, BIKTARVY … ,246 shares of common stock issued and outstanding.
GILEAD SCIENCES, INC …
-
Gilead Sciences's Earnings: A Preview
05 Nov 2024 15:24 GMT
… -3.0%
Performance of Gilead Sciences Shares
Shares of Gilead Sciences were trading at $89 … insights on Gilead Sciences.
The consensus rating for Gilead Sciences is Neutral, … .
Delving into Gilead Sciences's Background
Gilead Sciences develops and markets …